Literature DB >> 16176433

Which clinical factors predict response to prophylactic lithium? A systematic review for bipolar disorders.

N Kleindienst1, Rr Engel, W Greil.   

Abstract

OBJECTIVES: The aim of this study was to systematically integrate the available evidence on response prediction to prophylactic lithium based on clinical factors.
METHODS: Each clinical variable that was related to lithium response in at least one prior study was examined with respect to response prediction. If several studies were located for the same variable, results were integrated using the meta-analytic approach as suggested by DerSimonian and Laird which was developed for substantial heterogeneity in primary studies.
RESULTS: Of 42 potential clinical predictors investigated, five variables were identified as possible response predictors of prophylactic lithium: [1] An episodic pattern of mania-depression-interval, and [2] a high age of illness onset were identified as potentially protective against a recurrence under lithium. [3] A high number of previous hospitalizations, [4] an episodic pattern of depression-mania-interval, and [5] continuous cycling were identified as potential risk factors. Six further variables were found to be significantly related to lithium response, though calculation of fail-safe numbers indicates that current evidence is not sufficient to hold these variables as reliable predictors of lithium response. All effect-sizes relating clinical predictors to response were small to moderate.
CONCLUSIONS: Although a few variables are quite robustly supported as response-predictors in this review, a more in-depth analysis of each potential predictor is needed. As none of the potential predictors had a very strong impact on response, prediction of lithium response should be based on a multitude of variables.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16176433     DOI: 10.1111/j.1399-5618.2005.00244.x

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  38 in total

1.  Lithium Versus Other Mood-Stabilizing Medications in a Longitudinal Study of Youth Diagnosed With Bipolar Disorder.

Authors:  Danella M Hafeman; Brian Rooks; John Merranko; Fangzi Liao; Mary Kay Gill; Tina R Goldstein; Rasim Diler; Neal Ryan; Benjamin I Goldstein; David A Axelson; Michael Strober; Martin Keller; Jeffrey Hunt; Heather Hower; Lauren M Weinstock; Shirley Yen; Boris Birmaher
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2019-07-29       Impact factor: 8.829

2.  Lithium-responsive genes and gene networks in bipolar disorder patient-derived lymphoblastoid cell lines.

Authors:  M S Breen; C H White; T Shekhtman; K Lin; D Looney; C H Woelk; J R Kelsoe
Journal:  Pharmacogenomics J       Date:  2016-07-12       Impact factor: 3.550

Review 3.  Kidney, thyroid and other organ functions after 40 years or more of lithium therapy: a case series of five patients.

Authors:  Agnieszka Permoda-Osip; Maria Abramowicz; Agnieszka Kraszewska; Aleksandra Suwalska; Maria Chlopocka-Wozniak; Janusz K Rybakowski
Journal:  Ther Adv Psychopharmacol       Date:  2016-04-17

4.  Predictors of lithium response in bipolar disorder.

Authors:  Sarah K Tighe; Pamela B Mahon; James B Potash
Journal:  Ther Adv Chronic Dis       Date:  2011-05       Impact factor: 5.091

5.  Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder.

Authors:  Alessio Squassina; Mirko Manchia; Maria Del Zompo
Journal:  Hum Genomics Proteomics       Date:  2010-08-03

6.  The social, psychopathological and consumer context of rate of symptom improvement in acute mania.

Authors:  Jim van Os; Inge van Rossum; Maarten Boomsma; Eduard Vieta; Iris Goetz; Catherine Reed; Josep Maria Haro
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-06-27       Impact factor: 4.328

Review 7.  Personalized Pharmacotherapy for Bipolar Disorder: How to Tailor Findings From Randomized Trials to Individual Patient-Level Outcomes.

Authors:  Joseph F Goldberg
Journal:  Focus (Am Psychiatr Publ)       Date:  2019-07-16

Review 8.  Response to lithium in bipolar disorder: clinical and genetic findings.

Authors:  Janusz K Rybakowski
Journal:  ACS Chem Neurosci       Date:  2014-03-25       Impact factor: 4.418

9.  Clinical characteristics and long-term response to mood stabilizers in patients with bipolar disorder and different age at onset.

Authors:  Bernardo Dell'Osso; Massimiliano Buoli; Riccardo Riundi; Nazario D'Urso; Sara Pozzoli; Roberta Bassetti; Emanuela Mundo; A Carlo Altamura
Journal:  Neuropsychiatr Dis Treat       Date:  2009       Impact factor: 2.570

10.  Assessment of Response to Lithium Maintenance Treatment in Bipolar Disorder: A Consortium on Lithium Genetics (ConLiGen) Report.

Authors:  Mirko Manchia; Mazda Adli; Nirmala Akula; Raffaella Ardau; Jean-Michel Aubry; Lena Backlund; Claudio Em Banzato; Bernhard T Baune; Frank Bellivier; Susanne Bengesser; Joanna M Biernacka; Clara Brichant-Petitjean; Elise Bui; Cynthia V Calkin; Andrew Tai Ann Cheng; Caterina Chillotti; Sven Cichon; Scott Clark; Piotr M Czerski; Clarissa Dantas; Maria Del Zompo; J Raymond Depaulo; Sevilla D Detera-Wadleigh; Bruno Etain; Peter Falkai; Louise Frisén; Mark A Frye; Jan Fullerton; Sébastien Gard; Julie Garnham; Fernando S Goes; Paul Grof; Oliver Gruber; Ryota Hashimoto; Joanna Hauser; Urs Heilbronner; Rebecca Hoban; Liping Hou; Stéphane Jamain; Jean-Pierre Kahn; Layla Kassem; Tadafumi Kato; John R Kelsoe; Sarah Kittel-Schneider; Sebastian Kliwicki; Po-Hsiu Kuo; Ichiro Kusumi; Gonzalo Laje; Catharina Lavebratt; Marion Leboyer; Susan G Leckband; Carlos A López Jaramillo; Mario Maj; Alain Malafosse; Lina Martinsson; Takuya Masui; Philip B Mitchell; Frank Mondimore; Palmiero Monteleone; Audrey Nallet; Maria Neuner; Tomás Novák; Claire O'Donovan; Urban Osby; Norio Ozaki; Roy H Perlis; Andrea Pfennig; James B Potash; Daniela Reich-Erkelenz; Andreas Reif; Eva Reininghaus; Sara Richardson; Guy A Rouleau; Janusz K Rybakowski; Martin Schalling; Peter R Schofield; Oliver K Schubert; Barbara Schweizer; Florian Seemüller; Maria Grigoroiu-Serbanescu; Giovanni Severino; Lisa R Seymour; Claire Slaney; Jordan W Smoller; Alessio Squassina; Thomas Stamm; Jo Steele; Pavla Stopkova; Sarah K Tighe; Alfonso Tortorella; Gustavo Turecki; Naomi R Wray; Adam Wright; Peter P Zandi; David Zilles; Michael Bauer; Marcella Rietschel; Francis J McMahon; Thomas G Schulze; Martin Alda
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.